Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ACADIA Pharmaceuticals Inc ACAD

Healthcare Biotechnology
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders... see more

Recent & Breaking News (NDAQ:ACAD)

Pros And Cons Of All The News Out Of Acadia Pharma This Week

Benzinga.com  October 6, 2017

Acadia's FDA Breakthrough Designation For Pimavanserin Draws Mixed Response

Benzinga.com  October 5, 2017

Get a report before you buy ACADIA Pharmaceuticals, Deckers Outdoor Corp, GoPro, Shopify Inc. or United Parcel Service stock.

PR Newswire October 5, 2017

25 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  October 5, 2017

ACADIA Pharmaceuticals Initiates Phase III Study of Pimavanserin in Dementia-Related Psychosis

Business Wire October 4, 2017

Technical Reports on Biotech Equities -- Vanda Pharma, ACADIA Pharma, Achillion Pharma, and Agios Pharma

PR Newswire September 20, 2017

ACADIA Pharmaceuticals to Present at the Ladenburg Thalmann 2017 Healthcare Conference on September 26, 2017

Business Wire September 19, 2017

Adamas Pharma's Gocovri Approved, A Welcome Addition To Parkinson's Treatments

Benzinga.com  August 25, 2017

ACADIA Pharmaceuticals Reports Second Quarter 2017 Financial Results

Business Wire August 8, 2017

Investor Network: ACADIA Pharmaceuticals Inc. to Host Earnings Call

Accesswire August 8, 2017

ACADIA Pharmaceuticals to Announce Second Quarter 2017 Financial Results on August 8, 2017

Business Wire August 1, 2017

ACADIA Pharmaceuticals Named to Forbes Magazine’s List of World’s Most Innovative Growth Companies

Business Wire July 25, 2017

Today's Research Report Coverage on Biotech Stocks -- ACADIA Pharma, Aduro BioTech, Agios Pharma, and AveXis

PR Newswire July 20, 2017

Wall Street's M&A Chatter From June 21: Staples-Sycamore Partners, Diageo-Casamigos, Bristol-Myers, Acadia Pharma

Benzinga.com  June 22, 2017

InvestorsObserver releases covered-call reports for ACADIA Pharmaceuticals, Aerie Pharmaceuticals, Best Buy Inc., Marathon Oil Corporation and Walgreens Boots Alliance

PR Newswire May 26, 2017

ACADIA Pharmaceuticals Reports First Quarter 2017 Financial Results

Business Wire May 9, 2017

Investor Network: ACADIA Pharmaceuticals Inc. to Host Earnings Call

Accesswire May 9, 2017

ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference on May 16, 2017

Business Wire May 8, 2017

ACADIA Pharmaceuticals to Announce First Quarter 2017 Financial Results on May 9, 2017

Business Wire May 2, 2017

How These Biotech Stocks are Faring? -- ACADIA Pharma, Alexion Pharma, TG Therapeutics, and Esperion Therapeutics

PR Newswire April 24, 2017